Skip to main content

Ongoing FDAEvent 99745 (22 days ago)

Cardioroot Woven Collagen Coated Vascular Graft

The Cardioroot Woven Collagen Coated Vascular Graft failed water permeability acceptance criteria.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

INTERVASCULAR, SAS, of La Ciotat Cedex, France, recalled the Cardioroot Woven Collagen Coated Vascular Graft because the product failed to meet the specified acceptance criteria for Integral Water Permeability (IWP). The recall began August 12, 2026, and was added to the FDA's Enforcement Report on September 23, 2026. The graft was distributed worldwide, including US Nationwide and numerous countries.

The recall affects the graft models HEWROOT0024, HEWROOT0026, HEWROOT0028, HEWROOT0030, HEWROOT0032, and HEWROOT0034. The company initiated the recall due to the permeability issue.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

  1. Cardioroot Woven Collagen Coated Vascular Graft

    Model
    • HEWROOT0024
    • HEWROOT0026
    • HEWROOT0028
    • HEWROOT0030
    • HEWROOT0032
    • HEWROOT0034
    UDI-DI
    • 00384401013884
    • 00384401013891
    • 00384401013907
    • 00384401013914
    • 00384401013921
    • 00384401013938

Details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Albania, Algeria, Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Jordan, Kenya, Kosovo, Kuwait, Latvia, Luxembourg, Malaysia, Mauritius, Monaco, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Tunisia, Turkey, United Arab Emirates, United Kingdom, Yemen.

Event ID
99745
Recall No.
Z-3258-2026
Company
INTERVASCULAR, SASLa Ciotat Cedex, France
Quantity recalled
16329 (3880 US, 12449 OUS)
Recall type
Voluntary: Firm initiated
Customers told by
Letter
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration